PIPA5120716

SARS-CoV-2 NSP10 Polyclonal Antibody, Invitrogen™

Manufacturer: Thermo Scientific

Select a Size

Pack Size SKU Availability Price
Each of 1 PIPA5120716-Each-of-1 In Stock ₹ 44,811.50

PIPA5120716 - Each of 1

₹ 44,811.50

In Stock

Quantity

1

Base Price: ₹ 44,811.50

GST (18%): ₹ 8,066.07

Total Price: ₹ 52,877.57

Antigen

SARS-CoV-2 NSP10

Classification

Polyclonal

Conjugate

Unconjugated

Gene Alias

CoV; CoV-2; NSP10; SARS

Immunogen

Recombinant fusion protein containing a sequence corresponding to amino acids 1-139 of coronavirus NSP10 (YP_0097253061)

Quantity

100 μL

Primary or Secondary

Primary

Content And Storage

-20° C, Avoid Freeze/Thaw Cycles

Form

Liquid

Applications

Western Blot

Concentration

2.527 mg/mL

Formulation

PBS with 50% glycerol and 0.01% thimerosal; pH 7.3

Host Species

Rabbit

Purification Method

Affinity Chromatography

Regulatory Status

RUO

Target Species

Virus

Product Type

Antibody

Isotype

IgG

Related Products

Img

Thermo Scientific

PIPA5116916

--

Img

Thermo Scientific

PIPA5116597

--

Img

Thermo Scientific

PIPA5119593

--

Img

Thermo Scientific

PIPA569725

--

Img

Thermo Scientific

PIMA535941

--

Img

Thermo Scientific

PIPA552357

--

Img

Thermo Scientific

PIPA5114446

--

Img

Thermo Scientific

PIPA5121626

--

Description

  • Positive test controls include: 293T
  • Immunogen sequence: AGNATEVPAN STVLSFCAFA VDAAKAYKDY LASGGQPITN CVKMLCTHTG TGQAITVTPE ANMDQESFGG ASCCLYCRCH IDHPNPKGFC DLKGKYVQIP TTCANDPVGF TLKNTVCTVC GMWKGYGCSC DQLREPMLQ Severe Acute Respiratory Syndrome (SARS), an emerging disease characterized by atypical pneumonia, has recently been attributed to a novel coronavirus (SARS-CoV)
  • The nucleocapsid protein (N) was one of the structural proteins of SARS-CoV (N, S, sE, M)
  • The severe acute respiratory syndrome coronavirus (SARS-CoV) nucleocapsid (N) protein is the most abundant protein in the virus-infected cells
  • The SARS-CoV-2 S gene has 76% amino acid similarity to the SARS-CoV S gene, and nonsynonymous mutations developed in the S protein as the SARS-CoV epidemic developed, reports have shown that the crystal structure of the SARS-CoV-2 nucleocapsid protein is similar to those of previously described coronavirus N proteins, but their surface electrostatic potential characteristics are distinct.